» Articles » PMID: 39161701

Vicious Cycle of Oxidative Stress and Neuroinflammation in Pathophysiology of Chronic Vascular Encephalopathy

Overview
Journal Front Physiol
Date 2024 Aug 20
PMID 39161701
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic vascular encephalopathy (CVE) is a frequent cause of vascular mild cognitive impairment and dementia, which significantly worsens the quality of life, especially in the elderly population. CVE is a result of chronic cerebral hypoperfusion, characterized by prolonged limited blood flow to the brain. This causes insufficient oxygenation of the brain leading to hypoxia. The latter can trigger a series of events associated with the development of oxidative/reductive stresses and neuroinflammation. Addressing the gap in knowledge regarding oxidative and reductive stresses in the development of vascular disorders and neuroinflammation can give a start to new directions of research in the context of CVE. In this review, we consider the hypoxia-induced molecular challenges involved in the pathophysiology of CVE, focusing on oxidative stress and neuroinflammation, which are combined in a vicious cycle of neurodegeneration. We also briefly describe therapeutic approaches to the treatment of CVE and outline the prospects for the use of sulforaphane, an isothiocyanate common in cruciferous plants, and vitamin D to break the vicious cycle and alleviate the cognitive impairments characteristic of patients with CVE.

Citing Articles

Sodium Thiosulfate: An Innovative Multi-Target Repurposed Treatment Strategy for Late-Onset Alzheimer's Disease.

Hayden M, Tyagi N Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770582 PMC: 11676759. DOI: 10.3390/ph17121741.


Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases.

Kim S, Jung U, Kim S Antioxidants (Basel). 2025; 13(12.

PMID: 39765790 PMC: 11673141. DOI: 10.3390/antiox13121462.


Vascular Cognitive Impairment-The Molecular Basis and Potential Influence of the Gut Microbiota on the Pathological Process.

Olejnik P, Golenia A Cells. 2024; 13(23).

PMID: 39682711 PMC: 11639845. DOI: 10.3390/cells13231962.

References
1.
Poh L, Sim W, Jo D, Dinh Q, Drummond G, Sobey C . The role of inflammasomes in vascular cognitive impairment. Mol Neurodegener. 2022; 17(1):4. PMC: 8744307. DOI: 10.1186/s13024-021-00506-8. View

2.
Owolabi M, Ojagbemi A, Kalaria R, Sarfo F, Akinyemi R . Behavioural and Cognitive Effects of Cerebrovascular Diseases. Behav Neurol. 2018; 2018:7516032. PMC: 5924992. DOI: 10.1155/2018/7516032. View

3.
Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X . Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways. Sci Rep. 2016; 6:32206. PMC: 4995453. DOI: 10.1038/srep32206. View

4.
Zou H, Chen X, Lu J, Zhou W, Zou X, Wu H . Neurotropin alleviates cognitive impairment by inhibiting TLR4/MyD88/NF-κB inflammation signaling pathway in mice with vascular dementia. Neurochem Int. 2023; 171:105625. DOI: 10.1016/j.neuint.2023.105625. View

5.
OBrien J, Holmes C, Jones M, Jones R, Livingston G, McKeith I . Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2017; 31(2):147-168. DOI: 10.1177/0269881116680924. View